Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
MF-438
Cat. No.:
OB0225LY-0230
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
MF-438 is an effective stearoyl-CoA desaturase 1 (SCD1) inhibitor that regulates various cellular physiological processes.
Synonym:
921605-87-0; 2-Methyl-5-(6-(4-(2-(trifluoromethyl)phenoxy)piperidin-1-yl)pyridazin-3-yl)-1,3,4-thiadiazole; 3-(5-Methyl-1,3,4-thiadiazol-2-yl)-6-[4-[2-(trifluoromethyl)phenoxy]-1-piperidinyl]pyridazine; Pyridazine, 3-(5-methyl-1,3,4-thiadiazol-2-yl)-6-(4-(2-(trifluoromethyl)phenoxy)-1-piperidinyl)-; 2-Methyl-5-[6-[4-[2-(trifluoromethyl)phenoxy]piperidin-1-yl]pyridazin-3-yl]-1,3,4-thiadiazole
CAS No.:
921605-87-0
Compound CID:
16042458
Formula:
C19H18F3N5OS
Formula Weight:
421.44
Specification
Relative Density:
1.365 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
MF-438 can be used to study cell signaling pathways or play an important role in mechanistic studies of metabolic syndrome.
Library Information
Targets:
Dehydrogenase; Stearoyl-CoA desaturase (SCD)
Receptors:
SCD1
Pathways:
Metabolism
Plate Number:
AOCL-3
Plate Location:
h4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
45 mg/mL; 106.78 mM
